BLFS Share Price Performance
US$20.81
-1.29 (-5.82%)
33.1% undervalued intrinsic discount
US$31.10
Fair Value
Price US$20.81
AnalystConsensusTarget US$31.10
Fair ValueUS$31.10
Share PriceUS$20.81
33.1% undervalued intrinsic discount
BLFS Community Narratives
AN
Fair Value US$31.10 33.1% undervalued intrinsic discount
Expanding Cell And Gene Therapy Workflows Will Shape Future Opportunities
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
BLFS Community Fair Values
- US$31.10FV33.1% undervalued intrinsic discount20.12%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative2users have followed this narrative11 days ago author updated this narrative
Recent BLFS News & Updates
No updates
BioLife Solutions, Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 07, 2025
- Earnings per share (EPS)
- -0.18
- Gross Margin
- 65.19%
- Net Profit Margin
- -9.84%
- Debt/Equity Ratio
- 3.7%
BioLife Solutions, Inc. Competitors
About BLFS
- Founded
- 1987
- Employees
- 159
- CEO
- WebsiteView website
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
U.S. Market Performance
- 7 Days: -2.7%
- 3 Months: 11.4%
- 1 Year: 20.5%
- Year to Date: 5.9%
Over the last 7 days, the market has dropped 2.7%, driven by a pullback of 2.4% in the Information Technology sector. In contrast to the last week, the market is actually up 20% over the past year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading